News & Analysis on Clinical Trial Services & Contract Research And Development
Nanoform, Celanese: nanoparticle drug delivery partnership
By Jenni Spinner
- Last updated on
The two companies announced plans to collaborate on ways to jointly advance nanoparticle-enabled drug delivery. According to the firms, their goal is to assess the utility of combining Nanoform’s nanoparticle platform technologies with Celanese’s VitalDose EVA copolymer delivery technology for drug-eluting implants.
Edward Hæggström, CEO of Nanoform, said, “Given the inherent difficulty in loading a sufficient amount of drug into many medical devices, we see a tremendous opportunity in using our nanoparticles to overcome this fundamental challenge. The potential to leverage the combination of these two technologies to bring new therapies to patients is something we are very excited about.”